Showing 36,902 results

Filters
New & experimental hepatitis C treatment

Sofosbuvir and daclatasvir dual regimen cures most people with HCV genotypes 1, 2, or 3

News
21 November 2012
HIV treatment

New fixed-dose combination pills measure up to Atripla - corrected version*

News
20 November 2012
New & experimental hepatitis C treatment

Interferon-free hepatitis C treatment with faldaprevir proves safe and effective in people with cirrhosis

News
20 November 2012
Treatment outcomes & life expectancy

Life expectancy in older people with HIV could exceed the average – as long as ART keeps working

News
19 November 2012
New & experimental hepatitis C treatment

Simeprevir is safe and effective with interferon/ribavirin for hepatitis C patients with cirrhosis

News
19 November 2012
Cardiovascular disease

Smoking the biggest single risk factor for acute heart disease in people with HIV

News
19 November 2012
Pregnancy and vertical transmission

Lack of understanding of treatment benefits may discourage women with HIV from having children – and could increase the risk of vertical transmission

News
16 November 2012
Pregnancy and vertical transmission

Manchester study finds link between increased premature birth rate and HIV

News
15 November 2012
Undetectable viral load & treatment as prevention

Half of HIV-positive gay men disagree that HIV treatment makes you less infectious

News
15 November 2012
New & experimental hepatitis C treatment

Sofosbuvir demonstrates high response rate in interferon-free combination with ribavirin and GS-5885

News
15 November 2012
New & experimental hepatitis C treatment

94% response rate to HCV treatment without ribavirin or interferon in harder-to-treat

News
13 November 2012
Hepatitis C treatment side-effects

Reducing ribavirin and adding EPO are both good anaemia management strategies for people taking boceprevir

News
13 November 2012
New & experimental hepatitis C treatment

Abbott interferon-free combination 'promising' in harder-to-treat patients with hepatitis C

News
12 November 2012
New & experimental hepatitis C treatment

High rate of response to BMS HCV drugs in harder-to-treat patients – but interferon-free prospects differ by sub-genotype

News
12 November 2012
New & experimental hepatitis C treatment

Final study results show telaprevir is safe and effective for HIV/HCV co-infected people

News
12 November 2012
New & experimental hepatitis C treatment

New hepatitis C drugs danoprevir and mericitabine are safe and effective for prior non-responders and people with cirrhosis

News
12 November 2012
Hepatitis C symptoms & diagnosis

New cohort shows the impact of hepatitis B and hepatitis C on the 'baby boom' generation

News
11 November 2012
PrEP science

Recreational drug use associated with non-prescription use of HIV PrEP among gay men in Australia

News
10 November 2012
Vaginal rings & topical PrEP

Some sexual lubricants damage cells – but may not increase HIV risk

News
9 November 2012
Undetectable viral load & treatment as prevention

Only half of people on HIV treatment fit 'Swiss Statement' criteria for non-infectiousness in US study

News
9 November 2012
Epidemiology & behaviour

Sexual preference is a better guide to HIV risk in gay men than reported behaviour, Chinese study suggests

News
8 November 2012
Men who have sex with men (MSM)

Young gay men with HIV in the UK worry about disclosure, transmission and prosecution – older ones about confidence and sex

News
7 November 2012
Men who have sex with men (MSM)

Very high HIV incidence among men who have sex with men in Kenya

News
7 November 2012
Treatment outcomes & life expectancy

Death rates elevated at all CD4 counts below 500 in sub-Saharan Africa

News
6 November 2012